Table 1 Summary of mouse phenotypes of lung tumors and lungs

From: JNK1/2 represses Lkb1-deficiency-induced lung squamous cell carcinoma progression

Genotype

No.

Age (Month)

The percent (%) of phenotypes in mouse lungs

   

SCC-DS

SCC

SCC-DS + SCC

AD-DS

AD

AD-DS + AD

Lkb1 d/d

56

11–14

25.0

16.1

32.8

16.1

37.5

53.6

Pten d/d

12

12–13

0

0

0

16.7

8.3

25.0

P53 d/d

10

12–13

0

0

0

10.0

10.0

20.0

Mig6 d/d

12

9

0

0

0

8.3

0

8.3

Kras G12D

8

1

0

0

0

100

37.5

100

Smad4 d/d

9

11–13

0

0

0

0

0

0

WT

25

1–14

0

0

0

4.0

0

4.0

  1. Lkb1d/d: CCSPiCre Lkb1f/f; Ptend/d: CCSPiCrePtenf/f; P53d/d: CCSPiCrep53f/f; Mig6d/d: CCSPiCreMig6f/f; KrasG12D: CCSPiCreKrasG12D; Smad4d/d: CCSPiCreSmad4f/f; WT wild type. SCC development stages include epithelial hyperplasia, epithelial hyperplasia with squamous metaplasia, adenocarcinoma with squamous differentiation and adenosquamous carcinoma
  2. Adenocarcinoma development stages include epithelial hyperplasia and adenoma
  3. SCC squamous cell carcinoma, DS development stage, AD adenocarcinoma, No. number